在院前医疗环境中使用 REBOA:基于德尔菲法的首个协议提案。

Q3 Medicine
Oscar Thabouillot, Romain Jouffroy, Daniel Jost, Sebastien Beaume, Clement Derkenne, Romain Kedzierewicz, Stephane Travers, Tal M Horer, Bertrand Prunet
{"title":"在院前医疗环境中使用 REBOA:基于德尔菲法的首个协议提案。","authors":"Oscar Thabouillot, Romain Jouffroy, Daniel Jost, Sebastien Beaume, Clement Derkenne, Romain Kedzierewicz, Stephane Travers, Tal M Horer, Bertrand Prunet","doi":"10.55460/KR4W-7EKM","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The resuscitative endovascular balloon occlusion of the aorta (REBOA) technique controls abdominal, pelvic, junctional, and postpartum hemorrhage via aortic endoclamping. There are no protocols or clear indications guiding REBOA use in a two-tiered prehospital emergency medical system, as found in France. We conducted a Delphi study to clarify the indications and contraindications for REBOA application in such a system.</p><p><strong>Methods: </strong>We performed a Delphi study in three rounds with an international group of doctors with REBOA expertise and clinical experience (members of the EndoVascular and Trauma Management Society). Based on the consensus answers, complemented by existing data in the literature, we developed a protocol for REBOA use in a medicalized prehospital setting.</p><p><strong>Results: </strong>We identified 10 questions that were not answered in the literature and submitted them to 21 experts. Over three rounds, consensus was reached on these 10 questions. The most important ones were \"In your opinion, in a hemorrhagic patient, vascularly well-filled and whose hemodynamics remain unstable with 3mg/h of norepinephrine, should we inflate a REBOA to prevent the patients death and get them to the operating room alive?\" and \"In the case of REBOA placement (zone I) in the prehospital setting, would you agree that the maximum occlusion duration is approximately 30 minutes, with a partial or intermittent occlusion when possible?\"</p><p><strong>Conclusion: </strong>We propose a protocol for REBOA use in a medicalized prehospital setting. This protocol clarifies that hemorrhagic shock, despite a noradrenaline (also known as norepinephrine) dose of 0.6µg/kg/min, is considered too serious for the patient to be transported to the trauma center without REBOA. Moreover, it clarifies that a zone 1 REBOA should be inflated for maximum 30 minutes and with a partial occlusion strategy, if possible. This protocol should be updated based on feedback following the establishment of prehospital REBOA and large randomized studies.</p>","PeriodicalId":53630,"journal":{"name":"Journal of special operations medicine : a peer reviewed journal for SOF medical professionals","volume":" ","pages":"37-42"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"REBOA Use in a Medicalized Prehospital Setting Proposal for a First Protocol Based on the Delphi Method.\",\"authors\":\"Oscar Thabouillot, Romain Jouffroy, Daniel Jost, Sebastien Beaume, Clement Derkenne, Romain Kedzierewicz, Stephane Travers, Tal M Horer, Bertrand Prunet\",\"doi\":\"10.55460/KR4W-7EKM\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The resuscitative endovascular balloon occlusion of the aorta (REBOA) technique controls abdominal, pelvic, junctional, and postpartum hemorrhage via aortic endoclamping. There are no protocols or clear indications guiding REBOA use in a two-tiered prehospital emergency medical system, as found in France. We conducted a Delphi study to clarify the indications and contraindications for REBOA application in such a system.</p><p><strong>Methods: </strong>We performed a Delphi study in three rounds with an international group of doctors with REBOA expertise and clinical experience (members of the EndoVascular and Trauma Management Society). Based on the consensus answers, complemented by existing data in the literature, we developed a protocol for REBOA use in a medicalized prehospital setting.</p><p><strong>Results: </strong>We identified 10 questions that were not answered in the literature and submitted them to 21 experts. Over three rounds, consensus was reached on these 10 questions. The most important ones were \\\"In your opinion, in a hemorrhagic patient, vascularly well-filled and whose hemodynamics remain unstable with 3mg/h of norepinephrine, should we inflate a REBOA to prevent the patients death and get them to the operating room alive?\\\" and \\\"In the case of REBOA placement (zone I) in the prehospital setting, would you agree that the maximum occlusion duration is approximately 30 minutes, with a partial or intermittent occlusion when possible?\\\"</p><p><strong>Conclusion: </strong>We propose a protocol for REBOA use in a medicalized prehospital setting. This protocol clarifies that hemorrhagic shock, despite a noradrenaline (also known as norepinephrine) dose of 0.6µg/kg/min, is considered too serious for the patient to be transported to the trauma center without REBOA. Moreover, it clarifies that a zone 1 REBOA should be inflated for maximum 30 minutes and with a partial occlusion strategy, if possible. This protocol should be updated based on feedback following the establishment of prehospital REBOA and large randomized studies.</p>\",\"PeriodicalId\":53630,\"journal\":{\"name\":\"Journal of special operations medicine : a peer reviewed journal for SOF medical professionals\",\"volume\":\" \",\"pages\":\"37-42\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of special operations medicine : a peer reviewed journal for SOF medical professionals\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.55460/KR4W-7EKM\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of special operations medicine : a peer reviewed journal for SOF medical professionals","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55460/KR4W-7EKM","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

背景:主动脉血管内球囊闭塞复苏术(REBOA)通过主动脉内钳夹控制腹腔、盆腔、交界处和产后出血。在法国的两级院前急救系统中,还没有指导使用 REBOA 的方案或明确的适应症。我们开展了一项德尔菲研究,以明确在此类系统中应用 REBOA 的适应症和禁忌症:方法:我们与一组具有 REBOA 专业知识和临床经验的国际医生(血管内与创伤管理协会会员)进行了三轮德尔菲研究。根据共识答案,并辅以现有文献数据,我们制定了在医疗院前环境中使用 REBOA 的方案:我们确定了文献中没有回答的 10 个问题,并将其提交给 21 位专家。经过三轮讨论,我们就这 10 个问题达成了共识。其中最重要的问题是:"在您看来,对于血管充盈良好、使用 3 毫克/小时去甲肾上腺素后血流动力学仍不稳定的大出血患者,我们是否应该为其充气,以防止患者死亡并将其送往手术室?"以及 "在院前环境中置入 REBOA(I 区)的情况下,您是否同意最长闭塞时间约为 30 分钟,并在可能的情况下进行部分或间歇性闭塞?"结论:我们提出了在医疗院前环境中使用 REBOA 的方案。该方案明确指出,尽管去甲肾上腺素(又称去甲肾上腺素)的剂量为 0.6µg/kg/min,但失血性休克仍被视为过于严重的情况,如果不使用 REBOA,就不能将患者送往创伤中心。此外,该方案还明确指出,1 区 REBOA 的充气时间不应超过 30 分钟,并尽可能采用部分闭塞策略。该方案应根据院前 REBOA 建立后的反馈意见和大型随机研究进行更新。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
REBOA Use in a Medicalized Prehospital Setting Proposal for a First Protocol Based on the Delphi Method.

Background: The resuscitative endovascular balloon occlusion of the aorta (REBOA) technique controls abdominal, pelvic, junctional, and postpartum hemorrhage via aortic endoclamping. There are no protocols or clear indications guiding REBOA use in a two-tiered prehospital emergency medical system, as found in France. We conducted a Delphi study to clarify the indications and contraindications for REBOA application in such a system.

Methods: We performed a Delphi study in three rounds with an international group of doctors with REBOA expertise and clinical experience (members of the EndoVascular and Trauma Management Society). Based on the consensus answers, complemented by existing data in the literature, we developed a protocol for REBOA use in a medicalized prehospital setting.

Results: We identified 10 questions that were not answered in the literature and submitted them to 21 experts. Over three rounds, consensus was reached on these 10 questions. The most important ones were "In your opinion, in a hemorrhagic patient, vascularly well-filled and whose hemodynamics remain unstable with 3mg/h of norepinephrine, should we inflate a REBOA to prevent the patients death and get them to the operating room alive?" and "In the case of REBOA placement (zone I) in the prehospital setting, would you agree that the maximum occlusion duration is approximately 30 minutes, with a partial or intermittent occlusion when possible?"

Conclusion: We propose a protocol for REBOA use in a medicalized prehospital setting. This protocol clarifies that hemorrhagic shock, despite a noradrenaline (also known as norepinephrine) dose of 0.6µg/kg/min, is considered too serious for the patient to be transported to the trauma center without REBOA. Moreover, it clarifies that a zone 1 REBOA should be inflated for maximum 30 minutes and with a partial occlusion strategy, if possible. This protocol should be updated based on feedback following the establishment of prehospital REBOA and large randomized studies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.30
自引率
0.00%
发文量
91
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信